Our Team
Pulse Economics is led by senior health economics, market access and policy professionals with deep experience across PBAC, MSAC, pricing, reimbursement and government decision-making.
Our team combines technical rigour with practical judgement, bringing experience from evaluation, advisory and industry contexts.
We work closely with clients as trusted advisors, providing clear, independent advice grounded in how decisions are made in practice.
Managing Director
Oona Reardon is a health economist with more than 20 years of experience across private, public and academic settings, specialising in market access, pricing strategy, evidence planning and health policy. She brings first-hand experience evaluating PBAC and MSAC submissions, giving her a deep understanding of how evidence, modelling and value arguments are scrutinised in practice. This evaluator perspective underpins Pulse Economics’ approach and sets it apart in the market access landscape….[read more]
Associate Director
Carol Lee is a specialist in strategy development and clinical review for PBS and MBS reimbursement submissions. With an impressive tenure of over two decades in her field, Carol brings a wealth of expertise spanning various therapeutic areas, including cardiology, endocrinology, neurology, and oncology.
Throughout her career, Carol has developed many public reimbursement submissions and has particular expertise in literature reviews, clinical trial evaluations…[read more]
Associate Director
Dr Roy Ramiscal is a former MSAC evaluator and an expert in evidence synthesis, HTA submissions, and business model strategy. He plays a key role in translating analytical outputs into clear insights that resonate with payers and decision-makers. At Pulse Economics, Roy applies this background in early-stage business development, investment due diligence, market access and financial modelling to help clients secure PBS and MBS listings and navigate reimbursement pathways…[read more]
Manager
Lisa Barrett specialises in health outcomes research, an essential component to support economic evaluation. With an impressive 15 years of experience across various healthcare sectors, including clinical research and hospital and outpatient settings, Lisa brings a wealth of practical knowledge to her role.
Lisa’s proficiency extends to conducting clinician surveys and fostering essential collaborations between health economists, clinicians, patient advocacy groups, and government authorities…[read more]
Our deep industry engagement sets us apart. We’re proud members of leading professional associations and networks, locally and globally.
Why Clients Choose Us
Clients value our team for:
- Evaluator-informed insight into HTA and reimbursement processes
- Clear, independent advice grounded in evidence
- Integrated strategy, modelling and interpretation
- Direct access to senior consultants
- Collaborative, low-friction delivery
We’re trusted for our judgement as much as our technical expertise.
Learn how our team can support your market access pathway or policy decisions
